• 1. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P.R.China;
  • 2. Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou 730000, P.R.China;
  • 3. Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou 730000, P.R.China;
  • 4. Department of Social Science and Health Management, School of Public Health, Lanzhou University, Lanzhou 730000, P.R.China;
  • 5. Department of Breast Cancer, The Second Xiangya Hospital, Central South University, Changsha 410083, P.R.China;
  • 6. National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union, Beijing 100021, P.R.China;
  • 7. Department of Epidemiology and Biostatistics, School of Public Health, Center of Evidence-based Medicine and Clinical Research, Peking University, Beijing 100191, P.R.China;
  • 8. Primary Care Unit, School of Clinical Medicine, University of Cambridge, Cambridge CB1 8RN, UK;
  • 9. National Clinical Research Center of Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R.China;
  • 10. Orthopedic Department, Yantaishan Hospital, Yantai 264000, P.R.China;
  • 11. Department of Traditional Chinese Medicine, Jing'an District Central Hospital, Shanghai 200040, P.R.China;
  • 12. China National Health Development Research Center, Beijing 100191, P.R.China;
  • 13. School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, P.R.China;
  • 14. Evidence-based Medicine Center of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, P.R.China;
  • 15. School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 999077, P.R.China;
  • 16. Chinese EQUATOR Centre, Hong Kong 999077, P.R.China;
BIAN Zhaoxiang, Email: bianzxiang@gmail.com; TIAN Jinhui, Email: tianjh@lzu.edu.cn
Export PDF Favorites Scan Get Citation

The PRISMA aims to enhance the transparency and reporting quality of systematic reviews. PRISMA 2020 is an update version of PRISMA 2009, which was published in BMJ in March, 2021. This article compared the PRISMA 2020 and PRISMA 2009, interpreted PRISMA 2020 with representative examples, aiming to help Chinese scholars better understand and apply this reporting guideline, thus to improve the reporting quality of systematic reviews.

Citation: GAO Ya, LIU Ming, YANG Kelu, GE Long, LI Lun, LI Jiang, SUN Feng, YANG Zhirong, WU Shanshan, DONG Shengjie, ZHANG Tiansong, XIAO Yue, WU Jiarui, ZHANG Junhua, BIAN Zhaoxiang, TIAN Jinhui. Reporting guideline for systematic review: comparative analysis of PRISMA 2020 and PRISMA 2009. Chinese Journal of Evidence-Based Medicine, 2021, 21(5): 606-616. doi: 10.7507/1672-2531.202104143 Copy

  • Previous Article

    The design and construction of clinical practice guidelines database of traditional Chinese medicine (G-TCM)
  • Next Article

    Introduction to pilot and feasibility studies in medical research